Marker protein for type 2 diabetes

Details for Australian Patent Application No. 2010323235 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Badi, Laura; Ebeling, Martin; Matile, Hugues; Migliorini, Cristiano; Sabates Bellver, Jacob; Schindler, Thomas; Sebokova, Elena; Wang, Haiyan

Agent Spruson & Ferguson

Pub. Number AU-A-2010323235

PCT Pub. Number WO2011/064179

Priority 09177238.4 26.11.09 EP

Filing date 23 November 2010

Wipo publication date 3 June 2011

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

10 May 2012 PCT application entered the National Phase

  PCT publication WO2011/064179 Priority application(s): WO2011/064179

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010323240-Method for producing plastics using 1,6-hexanediol with an aldehyde content of less than 500 ppm

2010323233-Polyester resins